Monique Nilsson

8PUBLICATIONS
74CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 13, 2026
BLU-451, a CNS-Active, Potent, and Selective Small-Molecule Inhibitor Against Uncommon EGFR Mutations.

|Aug 19, 2025
The Activity of EGFR CAR NK and CAR T Cells against EGFR Inhibitor-Resistant NSCLC and Drug-Tolerant Persister Cells.

Yan Yang, Monique B Nilsson, Xiaoxing Yu

|Jan 13, 2025
Impact of Co-mutations and Transcriptional Signatures in Non-Small Cell Lung Cancer Patients Treated with Adagrasib in the KRYSTAL-1 Trial.

Marcelo V Negrao, Alvaro G Paula, David Molkentine

|Jan 03, 2023
IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC.

Sonia A Patel, Monique B Nilsson, Yan Yang

|Aug 15, 2022
Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy.

Sonia A Patel, Monique B Nilsson, Xiuning Le

|Sep 04, 2020
A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components.

Monique B Nilsson, Huiying Sun, Jacqulyne Robichaux

Pageof 2

Frequent Collaborators

7 joint publications

John V Heymach

4 joint publications

Alissa Poteete

3 joint publications

Lixia Diao

3 joint publications

Don L Gibbons